Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Tesla (NASDAQ:TSLA) Shares Drop After California Restricts Autopilot Branding

Tesla (NASDAQ:TSLA), a manufacturer of electric vehicles and energy storage solutions, closed at USD 467.26 on December 17, 2025, down 4.6% on the day. Trading volume reached 105 million shares, nearly 22% above the company’s three-month average of 85 million shares, following California DMV …

Team Kalkine | 17 December 2025

Tilray Brands (NASDAQ: TLRY) Climbs 27.5% Amid Federal Policy Discussion

On December 16, 2025,Tilray Brands (NASDAQ:TLRY)recorded a notable uptick in its share price, finishing the session up roughly 27.5% at USD 14.12. The move stood in contrast to broader market activity — theS&P 500saw a slight decline while theNasdaq Compositeedged higher, signalling divergence in …

Team Kalkine | 17 December 2025

Investors Await CPI Amid Fed Uncertainty, Commodity Rebound and Mixed Macro Signals

Market Movers:On Monday, the top gainers were AMC Robotics Corporation. (+101.51%), followed by B. Riley Financial, Inc. (+53.76%). On the contrary, Cadrenal Therapeutics, Inc. (-32.87%), and Duluth Holdings Inc. (-29.39%) declined the most the same day.

Team Kalkine | 17 December 2025

GE HealthCare (Nasdaq:GEHC) Secures Multi-Year Deal to Supply CT Scanners Across 38 Provinces

GE HealthCare (Nasdaq:GEHC) has signed a multi-year agreement to supply over 300 CT (computed tomography) scanners to public hospitals under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program. The deployment will cover all 38 provinces, including urban and remote regions, and is expected to …

Team Kalkine | 16 December 2025

HUTCHMED (NASDAQ:HCM) Doses First Patient in Phase I Trial for ATTC Therapy

HUTCHMED (China) Limited (NASDAQ:HCM) has announced the start of its global Phase I clinical development program for HMPL-A251, an antibody-targeted therapy conjugate (ATTC). The first patient received the initial dose on December 16, 2025, in China. The study is being conducted across multiple sites …

Team Kalkine | 16 December 2025

Crane NXT (NYSE:CXT) Completes Initial Antares Vision Acquisition Phase

Crane NXT, Co. (NYSE:CXT) has completed the first phase of its previously announcedacquisitioninvolving Antares Vision S.p.A., securing an ownership interest of approximately 32% on a fully diluted basis. The stake was acquired from Regolo S.p.A. and Sargas S.r.L., following the receipt of all required …

Team Kalkine | 16 December 2025

MAIA (NYSE:MAIA) Reports USD 1.51Mn Private Placement

MAIA Biotechnology, Inc. (NYSE:MAIA)a clinical-stage biopharmaceutical company, announced that it has entered into definitive agreements for a privateplacementinvolving the issuance of 1,233,488 shares of common stock. The shares are being sold at a purchase price of USD 1.224 per share to accredited investors and …

Team Kalkine | 16 December 2025

Accenture (NYSE:ACN) Secures Preferred Partner Status in Palantir (NASDAQ:PLTR) Agreement

Palantir Technologies Inc. (NASDAQ:PLTR) and Accenture (NYSE:ACN) have launched the Accenture Palantir Business Group to accelerate AI and data-driven solutions for enterprises globally. Accenture has been named a preferred global partner for enterprise transformation by Palantir.

Team Kalkine | 16 December 2025

Citigroup Updates Coverage on Madison Square Garden Sports (NYSE:MSGS)

Madison Square Garden Sports Corp. (NYSE:MSGS) was the subject of a recent analyst update from Citigroup, which raised its price target on the stock to USD 290.00. The brokerage maintained its existing rating, indicating a reassessment of valuation inputs rather than a shift in …

Aditi Sarkar | 16 December 2025

Gildan Activewear (NYSE:GIL) Rises on Analyst Target Revision After Hanesbrands Deal

On December 16, 2025,Gildan Activewear (NYSE:GIL)recorded a noticeable uptick in share price, with the session closing higher by approximately 6% to close at USD 63.33. Trading volume was above recent averages, reflecting elevated market interest in the stock during the session. This move occurred …

Team Kalkine | 16 December 2025
Support

Hi! How can we help you today?

Loading…